Crossmark

Traditional Chinese medicine combined with chemotherapy in the treatment of advanced non-small cell lung cancer: key drug screening and mechanism analysis

Crossref DOI link: https://doi.org/10.1007/s00210-024-03310-5

Published Online: 2024-07-29

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Yu

Xian, Zhengping

Wu, Fengjiao

Cao, Hongyu

Wang, Lihao

Tang, Qian

Du, Yanan

Zheng, Xuefang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No.21601025, No.21601024, NO. 21571025)

Dalian University (DLUXK-2023-YB-007)
License Information

Text and Data Mining valid from 2024-07-29

Version of Record valid from 2024-07-29
More Information

Article History

Received: 27 June 2024

Accepted: 16 July 2024

First Online: 29 July 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below